Bharat (BIBCL) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2023Income Metrics
Revenue
446.1M
Gross Profit
24.0M
5.38%
Operating Income
-160.1M
-35.88%
Net Income
-166.4M
-37.30%
EPS (Diluted)
-₹3.85
Balance Sheet Metrics
Total Assets
1.9B
Total Liabilities
1.0B
Shareholders Equity
882.1M
Debt to Equity
1.14
Cash Flow Metrics
Operating Cash Flow
87.5M
Free Cash Flow
108.9M
Revenue & Profitability Trend
Bharat Income Statement From 2019 to 2023
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 446.1M | 783.9M | 853.3M | 668.4M | 836.5M |
| Cost of Goods Sold | 422.1M | 660.5M | 883.5M | 619.2M | 796.9M |
| Gross Profit | 24.0M | 123.4M | -30.2M | 49.2M | 39.6M |
| Operating Expenses | 30.7M | 31.3M | 34.0M | 39.0M | 35.0M |
| Operating Income | -160.1M | -48.5M | -211.0M | -105.2M | -94.1M |
| Pre-tax Income | -222.7M | -96.9M | -242.1M | -142.0M | -73.7M |
| Income Tax | -56.3M | -9.3M | -61.0M | -39.9M | -15.8M |
| Net Income | -166.4M | -87.5M | -181.1M | -102.1M | -57.9M |
| EPS (Diluted) | -₹3.85 | -₹2.03 | -₹4.19 | -₹2.36 | -₹1.34 |
Income Statement Trend
Bharat Balance Sheet From 2019 to 2023
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 358.0M | 654.3M | 339.5M | 930.2M | 987.4M |
| Non-Current Assets | 1.5B | 1.5B | 700.3M | 338.1M | 262.2M |
| Total Assets | 1.9B | 2.1B | 1.0B | 1.3B | 1.2B |
| Liabilities | |||||
| Current Liabilities | 940.4M | 1.0B | 640.9M | 1.0B | 884.8M |
| Non-Current Liabilities | 63.9M | 61.1M | 58.5M | 56.5M | 58.1M |
| Total Liabilities | 1.0B | 1.1B | 699.4M | 1.1B | 942.8M |
| Equity | |||||
| Total Shareholders Equity | 882.1M | 1.1B | 340.4M | 204.7M | 306.8M |
Balance Sheet Composition
Bharat Cash Flow Statement From 2019 to 2023
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -222.7M | -96.9M | -242.1M | -142.0M | -73.7M |
| Operating Cash Flow | 87.5M | -295.9M | 365.3M | 340.9M | -781.5M |
| Investing Activities | |||||
| Capital Expenditures | 0 | 0 | 0 | -5.0K | -251.0K |
| Investing Cash Flow | 0 | 1.0K | 1.0K | -4.0K | -251.0K |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | -76.6M | 505.9M | -74.3M | -296.7M | 327.1M |
| Free Cash Flow | 108.9M | -421.2M | 117.8M | 340.8M | -321.2M |
Cash Flow Trend
Bharat Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-6.18
Price to Book
1.30
Price to Sales
13.38
PEG Ratio
-0.07
Profitability Ratios
Profit Margin
-241.59%
Operating Margin
-2,888.44%
Return on Equity
-21.00%
Return on Assets
-6.28%
Financial Health
Current Ratio
0.33
Debt to Equity
94.48
Beta
1.88
Per Share Data
EPS (TTM)
-₹4.18
Book Value per Share
₹18.24
Revenue per Share
₹1.77
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| bibcl | 1.0B | -6.18 | 1.30 | -21.00% | -241.59% | 94.48 |
| Biocon | 492.9B | 43.71 | 2.04 | 5.40% | 6.64% | 66.26 |
| OneSource Specialty | 229.1B | - | 3.89 | -0.55% | -1.24% | 16.03 |
| Dishman Carbogen | 40.6B | 1,233.57 | 0.70 | 0.06% | 0.12% | 40.97 |
| Zota Health Care | 33.3B | - | 20.32 | -24.83% | -20.55% | 65.72 |
| Panacea Biotec | 25.7B | 91.93 | 3.06 | -1.05% | -1.50% | 2.67 |
Financial data is updated regularly. All figures are in the company's reporting currency.